# Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease

> **NCT00584896** · PHASE3 · TERMINATED · sponsor: **Point Biomedical** · enrollment: 1000 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** PB127 for Injectable Suspension

## Key facts

- **NCT ID:** NCT00584896
- **Lead sponsor:** Point Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 1000 (ESTIMATED)
- **Why stopped:** Discontinued PB127 development program for business reasons
- **Last updated:** 2008-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00584896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00584896, "Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00584896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*